HighTower Advisors LLC Purchases 8,000 Shares of KORU Medical Systems, Inc. $KRMD

HighTower Advisors LLC raised its position in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 18.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 51,400 shares of the company’s stock after acquiring an additional 8,000 shares during the period. HighTower Advisors LLC’s holdings in KORU Medical Systems were worth $131,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in KRMD. Raymond James Financial Inc. bought a new stake in shares of KORU Medical Systems in the fourth quarter valued at $118,000. Northern Trust Corp raised its stake in shares of KORU Medical Systems by 11.2% in the fourth quarter. Northern Trust Corp now owns 79,175 shares of the company’s stock valued at $305,000 after buying an additional 7,967 shares during the period. Schonfeld Strategic Advisors LLC bought a new stake in shares of KORU Medical Systems in the fourth quarter valued at $143,000. Jane Street Group LLC raised its stake in shares of KORU Medical Systems by 67.0% in the fourth quarter. Jane Street Group LLC now owns 68,923 shares of the company’s stock valued at $265,000 after buying an additional 27,664 shares during the period. Finally, Balyasny Asset Management L.P. bought a new stake in shares of KORU Medical Systems in the fourth quarter valued at $84,000. 58.60% of the stock is currently owned by institutional investors.

KORU Medical Systems Stock Performance

Shares of KRMD opened at $4.06 on Friday. The firm has a market cap of $187.73 million, a PE ratio of -45.11 and a beta of 0.57. The stock’s fifty day moving average price is $3.77 and its two-hundred day moving average price is $3.20. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.91 and a quick ratio of 2.25. KORU Medical Systems, Inc. has a 1 year low of $1.86 and a 1 year high of $5.05.

KORU Medical Systems (NASDAQ:KRMD) last issued its earnings results on Wednesday, August 6th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.04. KORU Medical Systems had a negative return on equity of 26.77% and a negative net margin of 12.24%.The firm had revenue of $10.20 million for the quarter, compared to analyst estimates of $9.46 million. On average, equities research analysts forecast that KORU Medical Systems, Inc. will post -0.13 EPS for the current year.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.